[go: up one dir, main page]

SE0303135D0 - Controlled food effect composition - Google Patents

Controlled food effect composition

Info

Publication number
SE0303135D0
SE0303135D0 SE0303135A SE0303135A SE0303135D0 SE 0303135 D0 SE0303135 D0 SE 0303135D0 SE 0303135 A SE0303135 A SE 0303135A SE 0303135 A SE0303135 A SE 0303135A SE 0303135 D0 SE0303135 D0 SE 0303135D0
Authority
SE
Sweden
Prior art keywords
food effect
effect composition
controlled food
pharmaceutical composition
lipid material
Prior art date
Application number
SE0303135A
Other languages
English (en)
Inventor
Peter Kaufmann
Karin Bohlinder
Goeran Nilsson
Jan Holmbaeck
Original Assignee
Lipocore Holding Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipocore Holding Ab filed Critical Lipocore Holding Ab
Priority to SE0303135A priority Critical patent/SE0303135D0/sv
Publication of SE0303135D0 publication Critical patent/SE0303135D0/sv
Priority to EP04800388A priority patent/EP1686958A1/en
Priority to PCT/SE2004/001727 priority patent/WO2005051354A1/en
Priority to US10/580,786 priority patent/US20080044486A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0303135A 2003-11-25 2003-11-25 Controlled food effect composition SE0303135D0 (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE0303135A SE0303135D0 (sv) 2003-11-25 2003-11-25 Controlled food effect composition
EP04800388A EP1686958A1 (en) 2003-11-25 2004-11-24 Controlled food effect composition
PCT/SE2004/001727 WO2005051354A1 (en) 2003-11-25 2004-11-24 Controlled food effect composition
US10/580,786 US20080044486A1 (en) 2003-11-25 2004-11-24 Controlled Food Effect Composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0303135A SE0303135D0 (sv) 2003-11-25 2003-11-25 Controlled food effect composition

Publications (1)

Publication Number Publication Date
SE0303135D0 true SE0303135D0 (sv) 2003-11-25

Family

ID=29729152

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0303135A SE0303135D0 (sv) 2003-11-25 2003-11-25 Controlled food effect composition

Country Status (4)

Country Link
US (1) US20080044486A1 (sv)
EP (1) EP1686958A1 (sv)
SE (1) SE0303135D0 (sv)
WO (1) WO2005051354A1 (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110384701A (zh) * 2011-12-19 2019-10-29 萨利克斯药品有限公司 使用甲基纳曲酮口服组合物治疗和预防阿片类诱发型便秘的方法
US9078925B2 (en) * 2012-06-18 2015-07-14 Galephar Pharmaceutical Research, Inc. Pharmaceutical semi-solid composition of isotretinoin
WO2015130083A1 (ko) * 2014-02-25 2015-09-03 동아에스티 주식회사 용법이 개선된 엔테카비어를 함유하는 약학적 조성물
KR101633292B1 (ko) * 2014-02-25 2016-06-24 동아에스티 주식회사 용법이 개선된 엔테카비어를 함유하는 약학적 조성물
WO2015181802A2 (en) * 2014-05-29 2015-12-03 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition of isotretinoin
WO2016016742A1 (en) * 2014-07-31 2016-02-04 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition of isotretinoin
MX2020010909A (es) * 2018-04-17 2020-11-06 Poviva Corp Composiciones infundidas con agentes activos lipofilicos que tienen efecto alimentario reducido.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19819273A1 (de) * 1998-04-30 1999-11-11 Pharmatec International S Giul Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung
PE20001227A1 (es) * 1998-10-30 2000-11-06 Hoffmann La Roche Procesos para producir una composicion de isotretinoina
SE9804192D0 (sv) * 1998-12-03 1998-12-03 Scotia Lipidteknik Ab New formulation
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
PT1318791E (pt) * 2000-09-22 2004-11-30 Galephar M F Composicao farmaceutica semi-solida de isotretinoina

Also Published As

Publication number Publication date
US20080044486A1 (en) 2008-02-21
WO2005051354A1 (en) 2005-06-09
EP1686958A1 (en) 2006-08-09

Similar Documents

Publication Publication Date Title
BRPI0608297A2 (pt) composições de lipossomos
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
CY1113462T1 (el) Μορφη δοσολογιας περιεχουσα παντοπραζολη ως δραστικο συστατικο
BRPI0520669A2 (pt) dosagem farmacêutica que reduz o efeito do alimento encontrado para administração de atorvastatina
CY1113003T1 (el) Ευσταθη παρασκευασματα laquinimod
CY1112981T1 (el) Μεθοδος και συνθεση για την αγωγη της ρινιτιδας
AR051397A1 (es) Composicion farmaceutica
CY1110558T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
CY1109142T1 (el) Χαρακτηρισμος: σπειροκυκλικα παραγωγα κυκλοεξανιου
CY1118179T1 (el) Φαρμακευτικη συνθεση
GT200500363A (es) 3-amino-pirazol [3,4b] piridinas con inhibidores de proteintirosinquinasas, su preparacion y uso como medicamento.
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
CR8371A (es) Formulaciones de medicamento que contienen saborizantes con mejores propiedades farmaceuticas
AR109263A2 (es) Composición que comprende moxidectina
ECSP045493A (es) Nuevas composiciones farmacéuticas que contienen flibanserina polimorfo a
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
EP1781277A4 (en) COMBINED COMPOSITION
CY1119315T1 (el) Στερεες μορφες που περιεχουν μελοξικαμη με βελτιωμενη στοματικη γευση και η διαδικασια για τηn προετοιμασια τους
SE0303135D0 (sv) Controlled food effect composition
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
EA200501252A1 (ru) Липосомальная композиция, способ ее получения и лекарственное средство на ее основе (варианты)
SE0203817D0 (sv) New composition
CY1108865T1 (el) Υποκατεστημενες 2,5-διαμινομευθυλο-1η-πυρρολες
AR055352A1 (es) Composicion farmaceutica